denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Cleveland Clinic & AAMDS
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Diseases, Myeloid Malignancies
Hematology Disease Topics & Pathways:
Diseases, Myeloid Malignancies
Friday, December 4, 2020: 7:00 AM-10:00 AM
Chair:
Bhumika J. Patel, MD, Cleveland Clinic
Disclosures:
Patel: Alexion: Other: educational speaker, Speakers Bureau.
Speakers:
Kelly L. Bolton, MD, PhD, Memorial Sloan Kettering Cancer Center
,
Vikas Gupta, MD, FRCP, FRCPath, Princess Margaret Cancer Centre, University Health Network
,
Betty K. Hamilton, MD, Cleveland Clinic Foundation
,
Jeffrey E. Lancet, MD, H. Lee Moffitt Cancer Center & Research Institute
,
Jaroslaw P. Maciejewski, MD, PhD, Cleveland Clinic
and
Guillermo F Sanz, MD, PhD, Hematology Department, Hospital Universitario y Politécnico La Fe
Disclosures:
Bolton: GRAIL: Research Funding. Gupta: Incyte: Honoraria, Research Funding; Sierra Oncology: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pfizer: Consultancy; Bristol MyersSquibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding. Hamilton: Syndax Pharmaceuticals: Consultancy, Honoraria. Lancet: Abbvie: Consultancy; Agios Pharmaceuticals: Consultancy, Honoraria; Astellas Pharma: Consultancy; Celgene: Consultancy, Research Funding; Daiichi Sankyo: Consultancy; ElevateBio Management: Consultancy; Jazz Pharmaceuticals: Consultancy; Pfizer: Consultancy. Maciejewski: Alexion, BMS: Speakers Bureau; Novartis, Roche: Consultancy, Honoraria. Sanz: Abbvie Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; LaHoffman Roche Ltd.: Membership on an entity's Board of Directors or advisory committees; Takeda Pharmaceutical Ltd.: Membership on an entity's Board of Directors or advisory committees; Helsinn: Membership on an entity's Board of Directors or advisory committees.
The Cleveland Clinic Taussig Cancer Institute and AA & MDS International Foundation join together to present the symposium, Mastering the Treatment of Myeloid Malignancies in the Era of Personalized Medicine. This CME-certified activity provides an in-depth and up-to-date review of research related to the management and treatment strategies for patients with MDS, AML, myeloproliferative neoplasms, and myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
See more of: Satellite Symposia